VMI
ECYT

VHCP Management III’s Endocyte, Inc. Common Stock ECYT Stock Holding History

VHCP Management III’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-600,000
Closed -$10.7M – 18
2018
Q3 		$10.7M Buy
+600,000
New +$10.3M 8.05% 5

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

VHCP Management III's ECYT Position: Q4 2018 in Review

VHCP Management III sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 600,000 shares — an estimated $10.7M sold.

VHCP Management III first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $10.7M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • VHCP Management III reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • VHCP Management III sold 600,000 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $10.7M.
  • VHCP Management III first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • VHCP Management III's Endocyte, Inc. Common Stock position peaked at $10.7M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on VHCP Management III's 13F filing for Q4 2018, filed 13 Feb 2019.